Silybin suppresses ovarian cancer cell proliferation by inhibiting isocitrate dehydrogenase 1 activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Silybin suppresses ovarian cancer cell proliferation by inhibiting isocitrate dehydrogenase 1 activity

Published:2022-07-21 Issue:9 Volume:113 Page:3032-3043
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Wei Zibo¹^ORCID,Ye Shuangyan²,Feng Haipeng³^ORCID,Zeng Chong¹,Dong Xinhuai¹,Zeng Xiaokang¹^ORCID,Zeng Liming¹,Lin Xu¹,Liu Qiuzhen¹,Yao Jie¹⁴^ORCID

Affiliation:

1. Medical Research Center, Shunde Hospital Southern Medical University (The First People's Hospital of Shunde) Foshan China

2. Medical Research Center, The Eighth Affiliated Hospital Sun Yat‐Sen University Shenzhen China

3. Department of Pathology, Shunde Hospital Southern Medical University (The First People's Hospital of Shunde) Foshan China

4. Department of Laboratory Medicine, Shunde Hospital Southern Medical University (The First People's Hospital of Shunde) Foshan China

Funder

Guangdong Medical Research Foundation

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15470

Reference45 articles.

1. Ovarian cancer statistics, 2018

2. Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer

3. Silymarin as a New Hepatoprotective Agent in Experimental Cholestasis: New Possibilities for an Ancient Medication

4. Silymarin is a selective estrogen receptor β (ERβ) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats

5. Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the multifaceted effects of silymarin on melanoma: Focusing on the role of lipid-based nanocarriers;Journal of Drug Delivery Science and Technology;2024-09

2. Novel two‐tiered screening approach identifies synergistic combinations of natural compounds for prostate cancer prevention and treatment;Molecular Carcinogenesis;2024-01-10

3. Bovine Serum Albumin Nanoparticles Enhanced the Intranasal Bioavailability of Silybin in Rats;Pharmaceutics;2023-11-21

4. HDAC4-mediated Deacetylation of Glutaminase Facilitates Glioma Stemness;Current Cancer Drug Targets;2023-10

5. Regulative Roles of Metabolic Plasticity Caused by Mitochondrial Oxidative Phosphorylation and Glycolysis on the Initiation and Progression of Tumorigenesis;International Journal of Molecular Sciences;2023-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3